
Lab Owner Pleads Guilty to $89 Million Fraud Scheme
Last week saw two key lab-related cases, with the biggest involving a fraud scheme relating to cancer genetic testing.
Last week saw two key lab-related cases, with the biggest involving a fraud scheme relating to cancer genetic testing.
The owners face fraud charges in two different schemes, one involving urine drug testing and one involving COVID-19 testing.
Recent OIG report says Medicare could have saved up to $215.8 million on at-risk payments for G0483 definitive drug tests.
Recently announced enforcement actions saw three big settlements, with two of those coming from medical centers.
Though labs were again absent from recent key enforcement actions, sentences were handed down in other healthcare-related cases.